Investigators harnessed genomic data to discover that the previously identified E2F4 signature in breast cancer can be utilized to predict prognosis and response to therapy in bladder cancer.

Source: E2F4 signature can predict progression of bladder cancer


David Cottle

UBB Owner & Administrator